Sign In

Jack Bailey

Chief Executive Officer at G1 Therapeutics, Inc.

Jack Bailey is an esteemed executive known for his extensive career in the pharmaceutical and biotechnology industries. With a strong educational foundation from the prestigious UNC Kenan-Flagler Business School, Jack has cultivated a wealth of experience that positions him as a leader in healthcare innovation and business development. Currently serving as the Chief Executive Officer at G1 Therapeutics, Inc., he plays a pivotal role in steering the company toward achieving breakthroughs in cancer treatment.

Before joining G1 Therapeutics, Jack made significant contributions as a Board Member and Strategic Advisor, amplifying the impact of G1 on a national scale. His expertise has been invaluable in shaping the company's vision and strategy, helping to position it as a leader in the biotech field. His work focuses on improving patients' lives through innovative therapies, demonstrating his unwavering commitment to transforming cancer care.

Jack's previous experiences include being a Corporate Advisor at the Eshelman Institute for Innovation, where he provided strategic insights to foster innovation in the healthcare sector. Furthermore, his role as a Board Member at the UNC Health Care System showcases his dedication to enhancing healthcare services and improving patient outcomes in the community. In addition to these roles, Jack was also a Board Member at Emergo Therapeutics, guiding the company in its mission to develop significant pharmaceutical advancements.

Prior to his executive roles, Jack served as the President of U.S. Pharmaceuticals at GlaxoSmithKline (GSK), where he played a critical role in leading the company’s strategic direction and operational efficiency in the highly competitive pharmaceutical landscape. His tenure at GSK equipped him with invaluable insights into drug development processes and market access strategies, bolstering his credentials as an industry expert. Jack began his illustrious career at Eli Lilly and Company, where he gained foundational knowledge in pharmaceuticals that has served him well throughout his professional journey.

Related Questions

How did Jack Bailey's education at UNC Kenan-Flagler Business School influence his career trajectory in the pharmaceutical industry?
What strategies did Jack Bailey employ as the President of U.S. Pharmaceuticals at GSK to enhance the company's market position?
In what ways has Jack Bailey's leadership at G1 Therapeutics contributed to advancements in cancer treatment?
What are the key initiatives implemented by Jack Bailey during his tenure as Corporate Advisor at the Eshelman Institute for Innovation?
How has Jack Bailey's experience as a Board Member at UNC Health Care System shaped his perspectives on healthcare delivery and patient care?
Jack Bailey
Add to my network

Location

Raleigh, North Carolina, United States